TCRT

Latest SEC Filings & News for TCRT

2 most recent filings and news items mentioning TCRT. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day

curl "https://api.brieftape.com/v1/tickers/TCRT/news?limit=20"

Pull TCRT filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

OtherJun 29, 2026Neutral

Alaunos Announces Lower Liver Weight After Fat Adjustment in ALN1003 Study

Alaunos Therapeutics reported new preclinical data showing ALN1003 treatment resulted in lower liver weight after adjusting for body fat percentage in a 48-day diet-induced obesity study. This finding supports the efficacy hypothesis of ALN1003 and aligns with previous results sh

View filing at SEC.gov →

RegulatoryMay 26, 2026Positive

Alaunos reports ALN1003 shows broad metabolic improvements in obese mouse studies

Alaunos Therapeutics reported preclinical data showing its ALN1003 candidate demonstrated consistent improvements across multiple metabolic markers including body weight, insulin sensitivity, and liver health in diet-induced obese mice. The positive early-stage results support co

View filing at SEC.gov →

AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.